Stock Market Update
15-Jul-26 12:05 ET
Major averages near flat lines
Dow +107.39
at 52615.66,
Nasdaq +5.03
at 26133.04,
S&P +4.29
at 7547.88
[BRIEFING.COM] The major averages continue to trade just above their baselines at midday.
Novo Nordisk A/S (NVO 50.67, +1.60, +3.26%) holds a solid gain after The Wall Street Journal reported that its weight loss drug is moving ahead of Eli Lilly's (LLY 1145.20, -7.34, -0.64%). Additionally, the company confirmed that the European Commission has issued approval of Wegovy pill as the first oral GLP-1 for weight management in the EU.
In other health care news, Johnson & Johnson (JNJ 250.54, -3.31, -1.30%) moves lower despite reporting solid Q2 upside for both EPS and revenue while raising FY26 EPS and revenue guidance by more than the Q2 beat.
Meanwhile, Elevance Health (ELV 390.19, -36.60, -8.58%) moves sharply lower despite a beat-and-raise earnings report of its own.
